Premier Alternatives

bit.bio

Biotechnology · Cambridge, United Kingdom · Founded 2016 · Privately Held (backing)

Developer of a synthetic biology platform designed to provide human cells for research, drug discovery and cell therapy. bit.bio is based in Cambridge, United Kingdom and was founded in 2016. It was valued at $546 million at its later-stage round in Dec 2021, the last priced event on record. It has raised $234 million across 1 recorded round; the latest was a $138 million later-stage round in Dec 2021.

PMV mark · valuation
$546.3M
Oct 2026
Priced at
its later-stage round
Dec 2021
Total raised
$234.2M
Last round
Later Stage VC
Dec 2021
How much has bit.bio raised?
$234.2Macross 1 recorded rounds · Dec 2021 – Dec 2021

Most recently, bit.bio raised $138.3M in its Later Stage VC (Dec 2021).

Free account
More of bit.bio with a free account
  • ·The complete investor list: 35 names
  • ·Watch bit.bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

bit.bio round by round

1 rounds
Dec 2021Later Stage VC$138.3M▮
+ 1 more investors · free account

How much has bit.bio raised?

bit.bio has raised $234 million in total; 1 of its rounds is on record. The largest on record was a $138 million later-stage round in Dec 2021.

bit.bio investors

35 investors are on record for bit.bio, including Innovate UK, Metaplanet Holdings, Tech Nation Group and Puhua Capital. By type, the record holds 7 venture capital firms and 2 hedge funds. The later-stage round in Dec 2021 drew 18 investors.

For fundraisers
Raising for a company like bit.bio?

35 investors have backed bit.bio — start your target list with the firms already writing checks in biotechnology.

See all 35 investors →

Frequently asked about bit.bio

How much has bit.bio raised?
bit.bio has raised $234.2M in total across 1 recorded funding rounds.
When was bit.bio's last funding round?
bit.bio's most recent recorded round was Later Stage VC in Dec 2021, raising $138.3M.